Sphaera Pharma, founded in 2008, is an integrated drug discovery and development organization led by pharma and biotech professionals with global experience. Our goal is to bring innovative therapies to patients with unmet medical needs by developing a balanced portfolio of early stage discovery projects and clinical programs. Our global footprint, with headquarters in Singapore and subsidiaries in the US and India, allows us optimum access to global resources and expertise in a unique model to reinvigorate drug discovery and development.
Sphaera’s research facility in India has established in-house capabilities in ALL aspects of pre-clinical drug discovery and development. Our external alliances allow reliable access to specialized services such as in radio-chemistry, c-GMP manufacture, GLP studies, clinical formulations, structural biology and clinical development.
Sphaera’s research facility in India has established in-house capabilities in ALL aspects of pre-clinical drug discovery and development. Our external alliances allow reliable access to specialized services such as in radio-chemistry, c-GMP manufacture, GLP studies, clinical formulations, structural biology and clinical development.
Location: Singapore
Employees: 51-200
Founded date: 2008
Investors 1
| Date | Name | Website |
| - | Baring Pri... | bpepindia.... |
Mentions in press and media 2
| Date | Title | Description |
| 17.10.2014 | Funding Roundup: Which biotech, medtech and healthIT startups got investments this week? | $5 million equity raise Joint pain relief CEO: David Renzi Cardero Therapeutics – Sunnyvale, California $891,999 in equity raised of a proposed $1.5 million round Approaching cardiovascular and metabolic disease with a mitochondrial biogene... |
| - | Funding Roundup: Which biotech, medtech and healthIT startups got investments this week? | Each week, many millions are invested into life sciences startups. There are so many that often, they get lost in the weeds. We’re keeping track for you – based on regulatory filings reported to the SEC: Bergen Medical Products – Cedar Knol... |